CLVR - Clever Leaves Holdings Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD

Clever Leaves Holdings Inc.

Bodega 19B, Parque Industrial Tibitoc

IndustryDrug Manufacturers—Specialty & Generic
Full-time employees400

Key executives

NameTitlePayExercisedYear born
Mr. Andres FajardoCo-Founder, CEO & Director232.02kN/A1978
Mr. Henry R. Hague IIIChief Financial Officer311.02kN/A1972
Mr. Julian WilchesChief Regulatory Officer202.49kN/A1979
Mr. Gustavo EscobarChief Operating OfficerN/AN/AN/A
Ms. Marta Pinto LeiteGen. Counsel & Corp. Sec.N/AN/AN/A
Mr. Amit PandeyExec. VP of Fin.N/AN/A1982
Mr. Andrew MillerHead of Bus. Devel.N/AN/AN/A
Mr. Camilo BohorquezHead of ColombiaN/AN/AN/A
Ms. Caroline KliessManaging Director of GermanyN/AN/AN/A
Jackie KeshnerInvestor Relations Exec.N/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Clever Leaves Holdings Inc. operates in the botanical cannabinoid and nutraceutical industries. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. It also produces extracted products, including isolates, crude oil extracts, standardized extracts, and oral solutions, as well as tetrahydrocannabinol flower. The company was incorporated in 2017 and is based in Tocancipá, Colombia.

Corporate governance

Clever Leaves Holdings Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.